Survival Outcomes With or Without Risk-Reducing Mastectomy in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers
For women electing imaging surveillance over risk-reducing surgery, our results may offer reassurance that their breast cancer-specific survival and OS are unlikely to be compromised. However, breast cancer incidence rates are significantly reduced after BRRM compared with imaging surveillance, which may be important information for women with pv<i>BRCA</i><i>1/2</i> considering BRRM.
Authors
- N. Flaum
- F. Lalloo
- James A. Harvey
- S. Howell
- Ashu Gandhi
- D. Gareth Evans
- Lyndsey Highton
- Emma Woodward
- Claire Forde
- Elaine F. Harkness
Institutions
- Manchester Academic Health Science Centre (GB)
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
- Cancer Research UK Manchester Institute (GB)
- The Christie NHS Foundation Trust (GB)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1200/jco-25-00834
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00